These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

928 related articles for article (PubMed ID: 26988930)

  • 1. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
    Willems S; Schat A; van Noorden MS; Fiocco M
    Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The net benefit for time-to-event outcome in oncology clinical trials with treatment switching.
    Fukuda M; Sakamaki K; Oba K
    Clin Trials; 2023 Dec; 20(6):670-680. PubMed ID: 37455538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model selection for survival individualized treatment rules using the jackknife estimator.
    Honvoh GD; Cho H; Kosorok MR
    BMC Med Res Methodol; 2022 Dec; 22(1):328. PubMed ID: 36550398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust versus consistent variance estimators in marginal structural Cox models.
    Enders D; Engel S; Linder R; Pigeot I
    Stat Med; 2018 Oct; 37(24):3455-3470. PubMed ID: 29888510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of accelerated failure time data with dependent censoring using auxiliary variables via nonparametric multiple imputation.
    Hsu CH; Taylor JM; Hu C
    Stat Med; 2015 Aug; 34(19):2768-80. PubMed ID: 25999295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.
    Kawahara T; Shinozaki T; Matsuyama Y
    BMC Med Res Methodol; 2020 Jul; 20(1):204. PubMed ID: 32736528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the role of Volterra integral equations in self-consistent, product-limit, inverse probability of censoring weighted, and redistribution-to-the-right estimators for the survival function.
    Strawderman RL; Baer BR
    Lifetime Data Anal; 2024 Jul; 30(3):649-666. PubMed ID: 38512595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression models for the restricted residual mean life for right-censored and left-truncated data.
    Cortese G; Holmboe SA; Scheike TH
    Stat Med; 2017 May; 36(11):1803-1822. PubMed ID: 28106926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression with a right-censored predictor using inverse probability weighting methods.
    Matsouaka RA; Atem FD
    Stat Med; 2020 Nov; 39(27):4001-4015. PubMed ID: 32779274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Kaplan-Meier Estimator as an Inverse-Probability-of-Censoring Weighted Average.
    Satten GA; Datta S
    Am Stat; 2001; 55(3):207-210. PubMed ID: 28845048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double inverse-weighted estimation of cumulative treatment effects under nonproportional hazards and dependent censoring.
    Schaubel DE; Wei G
    Biometrics; 2011 Mar; 67(1):29-38. PubMed ID: 20560935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring.
    Latimer NR; Abrams KR; Siebert U
    BMC Med Res Methodol; 2019 Mar; 19(1):69. PubMed ID: 30935369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection Bias Due to Loss to Follow Up in Cohort Studies.
    Howe CJ; Cole SR; Lau B; Napravnik S; Eron JJ
    Epidemiology; 2016 Jan; 27(1):91-7. PubMed ID: 26484424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consistent estimation of the expected Brier score in general survival models with right-censored event times.
    Gerds TA; Schumacher M
    Biom J; 2006 Dec; 48(6):1029-40. PubMed ID: 17240660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable selection using inverse probability of censoring weighting.
    Kojima M
    Stat Methods Med Res; 2023 Nov; 32(11):2184-2206. PubMed ID: 37675496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A robust weighted Kaplan-Meier approach for data with dependent censoring using linear combinations of prognostic covariates.
    Hsu CH; Taylor JM
    Stat Med; 2010 Sep; 29(21):2215-23. PubMed ID: 20812302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards.
    Díaz I; Colantuoni E; Hanley DF; Rosenblum M
    Lifetime Data Anal; 2019 Jul; 25(3):439-468. PubMed ID: 29492746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of treatment effect adjusting for dependent censoring using the IPCW method: an application to a large primary prevention study for coronary events (MEGA study).
    Yoshida M; Matsuyama Y; Ohashi Y;
    Clin Trials; 2007; 4(4):318-28. PubMed ID: 17848493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reweighted estimators for additive hazard model with censoring indicators missing at random.
    Chen X; Cai J
    Lifetime Data Anal; 2018 Apr; 24(2):224-249. PubMed ID: 28766089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of censoring on learning Bayesian networks in survival modelling.
    Stajduhar I; Dalbelo-Basić B; Bogunović N
    Artif Intell Med; 2009 Nov; 47(3):199-217. PubMed ID: 19833488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.